These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2140973)

  • 1. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
    Cipolli C; Chiari G
    Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodology of a clinical controlled study of L-acetylcarnitine].
    Neri M; Cortelloni C; De Vreese L
    Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
    Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
    Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
    Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
    Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology of a controlled clinical study for cerebral aging evaluation.
    Vecchi GP; Neri M; Cortelloni C; De Vreese L; Sirotti C; Cipolli C; Fabbri L; Zerbini O
    Int J Clin Pharmacol Res; 1990; 10(1-2):145-52. PubMed ID: 2201654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
    Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
    Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methodological premises of statistical analysis of the data].
    Bamfi F; Girelli M
    Clin Ter; 1990 Mar; 132(6 Suppl):475-8. PubMed ID: 2140972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
    Genazzani E
    Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
    Bella R; Biondi R; Raffaele R; Pennisi G
    Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
    Arrigo A; Casale R; Buonocore M; Ciano C
    Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
    Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
    Garzya G; Corallo D; Fiore A; Lecciso G; Petrelli G; Zotti C
    Drugs Exp Clin Res; 1990; 16(2):101-6. PubMed ID: 2205455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.